Assignee
DEXCEL PHARMA TECHNOLOGIES LTD
IL·18 granted patents·16 pending applications·452 citations·filing 1999–2025
Top patents by PatentIndex Score
34 records- 0197US6531152B1Immediate release gastrointestinal drug delivery systemDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2000·Granted Mar 11, 2003·240 cites·44 claims
- 0291US6632451B2Delayed total release two pulse gastrointestinal drug delivery systemDEXCEL PHARMA TECHNOLOGIES LTD·Filed 1999·Granted Oct 14, 2003·131 cites·36 claims
- 0389US6703044B1Venlafaxine formulationsDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2002·Granted Mar 9, 2004·67 cites·63 claims
- 0488US10076494B2Stable orally disintegrating pharmaceutical compositionsDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2016·Granted Sep 18, 2018·11 cites·15 claims
- 0576US9278064B2Method for treating a periodontal diseaseDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2014·Granted Mar 8, 2016·1 cites·27 claims
- 0671US11304961B2Compositions comprising dexamethasoneDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2020·Granted Apr 19, 2022·1 cites·28 claims
- 0770US10774176B2Alternating and semi-alternating poly(ester-anhydride) copolymersDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2015·Granted Sep 15, 2020·1 cites·19 claims
- 0865US11986554B2Orally disintegrating compositionsDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2021·Granted May 21, 2024·0 cites·13 claims
- 0962US12454693B1Nucleic acids for inhibiting expression of transferrin receptor 2DEXCEL PHARMA TECHNOLOGIES LTD·Filed 2024·Granted Oct 28, 2025·0 cites·9 claims
- 1062US2014178469A1Stable benzimidazole formulationDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2013·Application pending·0 cites
- 1160US11299583B2Alternating and semi-alternating poly(ester-anhydride) copolymersDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2020·Granted Apr 12, 2022·0 cites·19 claims
- 1260US2022125730A1Method of manufacturing an orally disintigrating tabletDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2022·Application pending·0 cites
- 1359US10835488B2Stable orally disintegrating pharmaceutical compositionsDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2018·Granted Nov 17, 2020·0 cites·26 claims
- 1459US2018271790A1Stable benzimidazole formulationDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2017·Application pending·0 cites
- 1557US11077055B2Orally disintegrating compositionsDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2016·Granted Aug 3, 2021·0 cites·6 claims
- 1656US2006057204A1Pharmaceutical compositions containing venlafaxineDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2003·Application pending·0 cites
- 1755US2006280795A1Specific time-delayed burst profile delivery systemDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2005·Application pending·0 cites
- 1855US2026092281A1Methods for treatment of anemiaDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2025·Application pending·0 cites
- 1953US10537585B2Compositions comprising dexamethasoneDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2017·Granted Jan 21, 2020·0 cites·15 claims
- 2053US2025367148A1Methods for treating allan-herndon-dudley syndromeDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2025·Application pending·0 cites
- 2153US2008260818A1Controlled Absorption of Statins in the IntestineDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2006·Application pending·0 cites
- 2252US2017042806A1Orally disintegrating compositionsDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2016·Application pending·0 cites
- 2352US2009196889A1Controlled absorption of statins in the intestineDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2005·Application pending·0 cites
- 2452US2019125792A1Pharmaceutical compositions comprising ferric citrate and methods for the production thereofDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2019·Application pending·0 cites
- 2550US9889090B2Method for treating a periodontal diseaseDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2016·Granted Feb 13, 2018·0 cites·25 claims
- 2650US2010297226A1Multiple unit pharmaceutical formulationDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2007·Application pending·0 cites
- 2747US10172882B2Pharmaceutical compositions comprising ferric citrate and methods for the production thereofDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2015·Granted Jan 8, 2019·0 cites·24 claims
- 2845US2009274758A1Solid Composition for Intra-Oral Delivery of InsulinDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2006·Application pending·0 cites
- 2944US11141488B2Compositions comprising biodegradable copolymers for prolonged local release of an antibioticDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2017·Granted Oct 12, 2021·0 cites·21 claims
- 3044US11096948B2Methods for treating helicobacter infectionDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2017·Granted Aug 24, 2021·0 cites·16 claims
- 3144US2019209466A1Ophthalmic compositionsDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2017·Application pending·0 cites
- 3242US2019125676A1Compositions comprising proton pump inhibitors for oral administrationDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2017·Application pending·0 cites
- 3340US2004185009A1Composition and device for treating periodontal diseasesDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2003·Application pending·0 cites
- 3436US10736855B2Compositions comprising proton pump inhibitorsDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2017·Granted Aug 11, 2020·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when DEXCEL PHARMA TECHNOLOGIES LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →